Leveraging Cross-Linking Mass Spectrometry for Modeling Antibody-Antigen Complexes

Andrea Di Ianni1,2, Alessio Di Ianni3, Kyra Cowan4

  • 1NBE-DMPK Innovative BioAnalytics, Merck Serono RBM S.p.A., an Affiliate of Merck KGaA, Darmstadt, Germany, Via Ribes 1, Colleretto Giacosa (TO) 10010, Italy.

PubMed
Summary

Cross-linking mass spectrometry (XL-MS) aids in mapping antibody-antigen interactions. This study demonstrates XL-MS data